Your session is about to expire
← Back to Search
Behavioural Intervention
50K4Life Program for Increasing Physical Activity
N/A
Recruiting
Led By Jennifer J Salinas, Ph.D., LMSW
Research Sponsored by University of Texas, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult 18 years or older
Full-time school-based school district employee
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks, 8 months, 12, months 18 months up to 18 months.
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a program called 50K4Life to see if it can help school employees in 30 public schools to walk more. The program will be delivered in two phases. In the
Who is the study for?
This trial is for school employees in El Paso, Texas who are interested in increasing their walking activity. Participants will be involved in a study using the '50K4Life' program and possibly SMS text messaging to encourage more walking. Those who don't respond well may receive additional support through individual coaching or school-level interventions.
What is being tested?
The '50K4Life' program aims to boost walking among school workers using activity trackers and motivational strategies. The study has two phases: initially comparing the effectiveness of the program with or without SMS reminders, then offering extra help to schools that need it through personal coaching or group activities.
What are the potential side effects?
Since this trial focuses on increasing physical activity, side effects might include typical exercise-related issues such as muscle soreness, fatigue, or minor injuries. However, these are common when starting any new physical routine.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I work full-time for a school district.
Select...
I am not pregnant and can walk without help or devices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 8 weeks, 8 months, 12 months, 18 months up to 18 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks, 8 months, 12 months, 18 months up to 18 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Daily Step Count
Secondary study objectives
Body Mass Index
Cardiorespiratory Fitness (CVF)
Height
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
8Treatment groups
Experimental Treatment
Group I: Phase 2. Walking Challenge onlyExperimental Treatment1 Intervention
Participants meeting the step goal in Phase 1(WC only) will continue into Phase 2 without change.
Group II: Phase 2. Walking Challenge + SMS Text MessagesExperimental Treatment2 Interventions
Participants meeting their step goal in Phase 1 (WC + SMS Text Messages) will continue into Phase 2 without change.
Group III: Phase 2. 50K4Life + SMS Text Messages + SchoolsExperimental Treatment3 Interventions
Walking Challenge + SMS Messages + School-level interventions
Group IV: Phase 2. 50K4Life + SMS Text Messages + IndividualExperimental Treatment3 Interventions
Walking Challenge + SMS Messages + Individual level interventions
Group V: Phase 2. 50K4LIfe + SchoolExperimental Treatment2 Interventions
Walking Challenge + School-level interventions
Group VI: Phase 2. 50K4LIfe + IndividualExperimental Treatment2 Interventions
Walking Challenge + Individual level interventions.
Group VII: Phase 1. 50K4Life + SMS Text MessagesExperimental Treatment2 Interventions
Walking Challenge + SMS Messages
Group VIII: Phase 1. 50K4LIfe OnlyExperimental Treatment1 Intervention
Walking Challenge only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SMS Text Messaging
2018
N/A
~770
Individual
2013
N/A
~820
School
2012
N/A
~3140
Find a Location
Who is running the clinical trial?
University of Texas, El PasoLead Sponsor
16 Previous Clinical Trials
2,633 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
444 Previous Clinical Trials
1,413,245 Total Patients Enrolled
Jennifer J Salinas, Ph.D., LMSWPrincipal InvestigatorUniversity of Texas, El Paso